AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Atazanavir; Ritonavir in Nigeria
4 products registered with NAFDAC — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Atazor-R Tablets_ Tablet | A4-9623 | Emcure Nigeria Limited | active | 26 Aug 2030 |
| Atazanavir and Ritonavir Tablets 300 mg/100 mg Tablet | A4-100815 | Jyna Pharma Ltd | active | 1 May 2029 |
| Atazanavir & Ritonavir Tablets 300 mg/100 mg Tablet | B4-4610 | Hetero Labs Nigeria Limited | active | 27 Oct 2026 |
| Atazanavir (As Sulfate) And Ritonavir Tablets Tablet | B4-0196 | Healthline Limited | active | 9 Nov 2025 |
Atazanavir; Ritonavir — NAFDAC Registration Details
NAFDAC (Nigeria) has 4 registered products containing Atazanavir; Ritonavir, of which 4 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Atazanavir; Ritonavir registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.